Hanoi, June 24, 2024 - On the afternoon of June 24, with the participation of leading doctors from the specialties of Hepatothe specialties of Hepato-Pancreato-Biliary, Emergency Resuscitation, and Nuclear Medicine, VinBrain officially launched its latest feature "LI-RADS classification on the DrAid™ CT Liver Cancer D&T” in Hanoi. This feature utilizes cutting-edge AI technology to analyze CT scans, precisely evaluating the risk of hepatocellular carcinoma (HCC) according to LI-RADS standards, and represents a pioneering development globally. Beyond classification, it provides interpretations and other critical criteria based on AI algorithms, including non-rim arterial phase hyperenhancement (APHE), non-peripheral "washout”, capsule, size and tumor growth within 6 months.
Interface displaying AI results with LI-RADS criteria interpretation
The distinguished event was graced by esteemed international experts, including Dr. Gregory Moore (Former Deputy President of Microsoft and Google Health Division) and Mr. Jonathan T. Fried (Former Canadian Ambassador to Japan and the WTO), visiting Vietnam as members of VinBrain's Board and Advisory Board. Also in attendance were Vietnamese leading healthcare experts such as Assoc. Prof. Dr. Nguyen Duy Thang (Chairman of Hanoi Society Gastroenterology), Dr. Phung Nam Lam (Deputy General Director of Professional Affairs and Head of the Emergency Resuscitation Subcommittee, Vinmec Hospital), Prof. Dr. Nguyen Thanh Liem (Director of the Institute of Stem Cell Research and Gene Technology, Vinmec Hospital), Dr. Nguyen Ngoc Quang (Medical Director of the Resuscitation - Emergency department, Vinmec Hospital), Assoc. Prof. Dr. Dao Viet Hang (Deputy Director of Endoscopy department, Hanoi Medical University Hospital), Dr. Vu Van Quang (Deputy Head of Hepato-Pancreato-Biliary department, 108 Military Central Hospital), Dr. Mai Hong Son (Deputy Head of the Nuclear Medicine department, 108 Military Central Hospital) ...
"VinBrain has developed a truly impressive feature that I haven't seen from any other entity," commented Dr. Moore.
CEO of VinBrain, Mr. Steven Truong, shared that this is a breakthrough in liver cancer diagnosis and treatment utilizing AI technology. The application of Explainable AI in this new feature helps provide reliable and substantiated interpretation of liver lesions, aiding doctors in reducing diagnostic errors and ensuring consistency in treatment evaluation.
VinBrain’s CEO Steven Truong spoke at the launch
Dr. Phung Nam Lam, Deputy General Director of Professional Affairs and Head of the Emergency Resuscitation Subcommittee, Vinmec Hospital, said: "With this new feature, we have another tool supporting medical experts such as pathologists, clinical practitioners and surgeons. It gives them a reliable source to assess a patient's risk for Hepatocellular Carcinoma (HCC). This is crucial because not all patients can undergo biopsy, or sometimes biopsies aren't even an option."
This event marks 6 months since the debut of DrAid™ CT Liver Cancer D&T, the world's pioneering platform for liver cancer detection and treatment, in Chicago, US. The launching of LI-RADS classification feature is a proof of VinBrain's relentless effort in developing groundbreaking AI solutions, bringing significant benefits to both doctors and patients. We are currently awaiting US FDA clearance, aiming to commercialize this groundbreaking product in the world's most rigorous market. VinBrain was also the first unit in Southeast Asia to obtain FDA clearance for DrAid™ Radiology V1 with features suggestive of pneumothorax in 2022.
Top
